Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Barriers to HIV treatment among people who use injection drugs implications for ‘treatment as prevention’

Barriers to HIV treatment among people who use injection drugs implications for ‘treatment... REVIEW URRENT Barriers to HIV treatment among people who use PINION injection drugs: implications for ‘treatment as prevention’ a a,b a,b Michael-John Milloy , Julio Montaner , and Evan Wood Purpose of review Recent research has confirmed the efficacy of employing highly active antiretroviral therapy (HAART) to prevent the transmission of HIV. However, barriers to the use of HAART among people who use injection drugs (PWIDs) remain an international concern. We review recent findings regarding factors determining effective HIV treatment among PWIDs and describe their possible impact on efforts to curb HIV incidence using HAART. Recent findings Internationally, HIV-seropositive PWIDs continue to experience suboptimal HIV treatment outcomes compared with other risk groups. Recent findings have better elucidated the role of ongoing illicit drug use in limiting access and adherence to HAART. However, recent research has also increasingly demonstrated the important role that social, environmental and structural factors, resulting from the criminalization of PWIDs, have in placing barriers to optimal HAART use among this population. Summary Treatment as prevention strategies for PWIDs will only be maximally effective if structural barriers to effective addiction and HIV treatment, which stem from the ongoing criminalization of this population, are addressed. Keywords AIDS, antiretroviral http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Opinion in HIV and Aids Wolters Kluwer Health

Barriers to HIV treatment among people who use injection drugs implications for ‘treatment as prevention’

Wood, Evan
Current Opinion in HIV and Aids , Volume 7 (4) – Jul 1, 2012
Download PDF
7 pages

Loading next page...
 
/lp/wolters-kluwer-health/barriers-to-hiv-treatment-among-people-who-use-injection-drugs-gIaY4dPmxT

References (90)

Copyright
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
ISSN
1746-630X
eISSN
1746-6318
DOI
10.1097/COH.0b013e328354bcc8
pmid
22576468
Publisher site
See Article on Publisher Site

Abstract

REVIEW URRENT Barriers to HIV treatment among people who use PINION injection drugs: implications for ‘treatment as prevention’ a a,b a,b Michael-John Milloy , Julio Montaner , and Evan Wood Purpose of review Recent research has confirmed the efficacy of employing highly active antiretroviral therapy (HAART) to prevent the transmission of HIV. However, barriers to the use of HAART among people who use injection drugs (PWIDs) remain an international concern. We review recent findings regarding factors determining effective HIV treatment among PWIDs and describe their possible impact on efforts to curb HIV incidence using HAART. Recent findings Internationally, HIV-seropositive PWIDs continue to experience suboptimal HIV treatment outcomes compared with other risk groups. Recent findings have better elucidated the role of ongoing illicit drug use in limiting access and adherence to HAART. However, recent research has also increasingly demonstrated the important role that social, environmental and structural factors, resulting from the criminalization of PWIDs, have in placing barriers to optimal HAART use among this population. Summary Treatment as prevention strategies for PWIDs will only be maximally effective if structural barriers to effective addiction and HIV treatment, which stem from the ongoing criminalization of this population, are addressed. Keywords AIDS, antiretroviral

Journal

Current Opinion in HIV and Aids – Wolters Kluwer Health

Published: Jul 1, 2012

There are no references for this article.